AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars
Sep. 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Sep. 8, 2026

Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director

Indeterminate GlobeNewswire
CPTx appoints Matt Kane as Chief Financial Officer
Sep. 8, 2026

CPTx appoints Matt Kane as Chief Financial Officer

Indeterminate GlobeNewswire
Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today
Sep. 8, 2026

Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today

Indeterminate GlobeNewswire
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
Sep. 8, 2026

Collegium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference
Sep. 8, 2026

Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program
Sep. 8, 2026

Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
Sep. 8, 2026

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Big Brothers Big Sisters Calls on Canadians to Make Life Bigger for Young People
Sep. 8, 2026

Big Brothers Big Sisters Calls on Canadians to Make Life Bigger for Young People

Indeterminate GlobeNewswire
Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer
Sep. 8, 2026

Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer

Indeterminate GlobeNewswire
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
Sep. 8, 2026

MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Indeterminate GlobeNewswire
Grands Frères Grandes Sœurs invite les Canadiennes et Canadiens à ouvrir des horizons pour les jeunes
Sep. 8, 2026

Grands Frères Grandes Sœurs invite les Canadiennes et Canadiens à ouvrir des horizons pour les jeunes

Indeterminate GlobeNewswire
Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring® Implant and Delivery System Procedures
Sep. 8, 2026

Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring® Implant and Delivery System Procedures

Indeterminate GlobeNewswire
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
Sep. 8, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire
Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.